Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study.

OBJECTIVE To examine the associations of the serum cystatin C level and chronic kidney disease with the incidence of age-related macular degeneration (AMD) over 15 years. METHODS In this population-based cohort study of 4926 individuals aged 43 to 86 years at baseline, 3779 participated in 1 or more follow-up examinations. Age-related macular degeneration was determined by grading photographs of the macula. Individuals were defined as having mild or moderate to severe chronic kidney disease based on a value of more than 45 mL/min/1.73 m(2) to 60 mL/min/1.73 m(2) or less and 45 mL/min/1.73 m(2) or less, respectively, according to the Modification of Diet in Renal Disease Study equation. RESULTS While controlling for age and other risk factors, the level of serum cystatin C at baseline was associated with the incidence of early AMD (odds ratio per log standard deviation [95% confidence interval], 1.16 [1.01-1.35]) and exudative AMD (1.42 [1.03-1.96]) but not geographic atrophy (0.89 [0.56-1.41]) or progression of AMD (1.02 [0.88-1.18]). Mild chronic kidney disease was associated with the 15-year cumulative incidence of early AMD (odds ratio per log standard deviation, 1.36 [95% confidence interval, 1.00-1.86]) but not the incidence of other AMD end points. CONCLUSION There is a relationship between the level of serum cystatin C and chronic kidney disease with the incidence of AMD. The underlying biological processes remain to be determined.

[1]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[2]  U. Felbor,et al.  Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.

[3]  R. Klein,et al.  Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. , 2001, Ophthalmology.

[4]  R. Klein,et al.  Changes in visual acuity in a population. The Beaver Dam Eye Study. , 1996, Ophthalmology.

[5]  R. Klein,et al.  Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.

[6]  A. Barrett,et al.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.

[7]  M. Blumenkranz,et al.  Risk factors in age-related maculopathy complicated by choroidal neovascularization. , 1986, Ophthalmology.

[8]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  E. Im,et al.  Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.

[10]  J. Alexander,et al.  Mouse podocyte complement factor H: the functional analog to human complement receptor 1. , 2007, Journal of the American Society of Nephrology : JASN.

[11]  J. Wassélius,et al.  Identification and localization of retinal cystatin C. , 2001, Investigative ophthalmology & visual science.

[12]  W. Bode,et al.  cystatins: protein inhibitors of cysteine proteinases , 2001 .

[13]  D. Spiegelman,et al.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.

[14]  Ronald Klein,et al.  Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. , 2006, American journal of ophthalmology.

[15]  T. Wienker,et al.  The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster. , 1998, American journal of human genetics.

[16]  M. Pericak-Vance,et al.  Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[18]  C. Nordgaard,et al.  Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.

[19]  Y. Tsao,et al.  Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. , 2006, Life Science.

[20]  D. Pérez-Caballero,et al.  Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.

[21]  T. Shohat,et al.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. , 2000, American journal of human genetics.

[22]  D. Levy,et al.  Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  J. Morrow,et al.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. , 2004, Kidney international.

[24]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[25]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[26]  Cm Taylor.  Complement factor H and the haemolytic uraemic syndrome , 2001, The Lancet.

[27]  T. Barka,et al.  Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye , 1994, The Anatomical record.

[28]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[29]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[30]  H. Tsukaguchi,et al.  A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. , 2000, Journal of the American Society of Nephrology : JASN.

[31]  Tiansen Li,et al.  Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function , 2004, The EMBO journal.

[32]  R. Nitsch,et al.  CST3 genotype associated with exudative age related macular degeneration , 2002, The British journal of ophthalmology.

[33]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[34]  I. Grierson,et al.  Fate of cystatin C lacking the leader sequence in RPE cells. , 2003, Experimental eye research.

[35]  S C Jensen,et al.  Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.

[36]  Ronald Klein,et al.  Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.

[37]  Usha Chakravarthy,et al.  Prevalence of age related maculopathy in northern India , 2004 .

[38]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[39]  R. Klein,et al.  The Beaver Dam Eye Study: visual acuity. , 1991, Ophthalmology.

[40]  R. Klein,et al.  The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. , 1991, American journal of epidemiology.

[41]  Barrett Aj,et al.  The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.

[42]  P. Mitchell,et al.  CKD increases the risk of age-related macular degeneration. , 2008, Journal of the American Society of Nephrology : JASN.

[43]  V. Sheffield,et al.  Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. , 1999, American journal of human genetics.

[44]  J. Alexander,et al.  Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. , 2004, Journal of the American Society of Nephrology : JASN.

[45]  G. Deschênes,et al.  Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.

[46]  D. Lenk,et al.  Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries , 2003, Journal of medical genetics.

[47]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[48]  U. Felbor,et al.  Collagen XVIII/endostatin structure and functional role in angiogenesis. , 2000, Cell structure and function.

[49]  F. Leighton,et al.  Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. , 2001, Kidney international.

[50]  M. Landray,et al.  Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  A. Barrett.  The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.

[52]  R. Klein,et al.  Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. , 2005, Archives of ophthalmology.

[53]  R. Sullivan,et al.  Transporters and Oxidative Stress in AMD , 2005 .

[54]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  P. Zipfel,et al.  An interactive web database of factor H‐associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease‐associated mutations , 2006, Human mutation.

[56]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[57]  R. Klein,et al.  Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. , 1998, American journal of epidemiology.

[58]  J L McRae,et al.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.

[59]  G. Filler,et al.  Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.